Nathaniel S. Gardiner
2018
In 2018, Nathaniel S. Gardiner earned a total compensation of $1.4M as Senior Vice President and General Counsel at Enanta Pharmaceuticals, a 9% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $148,320 |
---|---|
Option Awards | $577,165 |
Salary | $398,850 |
Stock Awards | $232,925 |
Other | $18,851 |
Total | $1,376,111 |
Gardiner received $577.2K in option awards, accounting for 42% of the total pay in 2018.
Gardiner also received $148.3K in non-equity incentive plan, $398.9K in salary, $232.9K in stock awards and $18.9K in other compensation.
Rankings
In 2018, Nathaniel S. Gardiner's compensation ranked 7,585th out of 14,244 executives tracked by ExecPay. In other words, Gardiner earned more than 46.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,585 | 47th |
Manufacturing | 2,944 | 49th |
Chemicals And Allied Products | 1,103 | 48th |
Drugs | 933 | 48th |
Pharmaceutical Preparations | 729 | 47th |
Gardiner's colleagues
We found four more compensation records of executives who worked with Nathaniel S. Gardiner at Enanta Pharmaceuticals in 2018.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019